首页> 美国卫生研究院文献>ACS Medicinal Chemistry Letters >Antitubercular Nitroimidazoles Revisited: Synthesisand Activity of the Authentic 3-Nitro Isomer of Pretomanid
【2h】

Antitubercular Nitroimidazoles Revisited: Synthesisand Activity of the Authentic 3-Nitro Isomer of Pretomanid

机译:再谈抗结核硝基咪唑:合成前manmanid的真实3-硝基异构体的合成和活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A published study of structural features associated with the aerobic and anaerobic activities of 4- and 5-nitroimidazoles had found that the 3-nitro isomer of pretomanid, >8, displayed interesting potencies, including against nitroreductase mutant Mycobacterium tuberculosis. However, recent nuclear magnetic resonance analyses of two trace byproducts, isolated from early process optimization studies toward a large-scale synthesis of pretomanid, raised structural assignment queries, particularly for >8, stimulating further investigation. Following our discovery that the reported compound was a 6-nitroimidazooxazole derivative, we developed a de novo synthesis of authentic >8 via nitration of the chiral des-nitro imidazooxazine alcohol >26 in trifluoroacetic or acetic anhydride, and verified its identity through an X-ray crystal structure. Unfortunately, >8 displayed no antitubercular activity (MICs > 128 μM), whereas the second byproduct (3′-methyl pretomanid) was eight-fold more potentthan pretomanid in the aerobic assay. These findings further clarifytarget specificities for bicyclic nitroimidazoles, which may becomeimportant in the event of any future clinical resistance.
机译:一项与4-和5-硝基咪唑的需氧和厌氧活性相关的结构特征的已发表研究发现,前manmanantid > 8 的3-硝基异构体显示出有趣的功效,包括对抗硝基还原酶突变型结核分枝杆菌的作用。 。然而,最近从早期工艺优化研究转向大规模合成前驱体的两个痕量副产物的核磁共振分析提出了结构分配查询,尤其是对于> 8 ,这刺激了进一步的研究。在发现所报告的化合物为6-硝基咪唑并恶唑衍生物之后,我们通过在三氟乙酸中硝化手性去硝基咪唑并恶唑醇> 26 ,从头合成了真正的> 8 。或乙酸酐,并通过X射线晶体结构验证其身份。不幸的是,> 8 没有显示出抗结核活性(MIC> 128μM),而第二种副产物(3'-甲基苯甲醚)的效价高八倍。在有氧测定中比类风湿性关节炎前。这些发现进一步澄清了双环硝基咪唑的目标特异性,可能成为在将来出现任何临床耐药性时很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号